| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 06/14/2006 | EP1339683B1 Estrogen receptor modulators |
| 06/14/2006 | EP1309315B1 Rapidly disintegrating oral formulation of valdecoxib |
| 06/14/2006 | EP1286667B1 Composition for the treatment and/or the prevention of osteoporosis and/or inflammatory joint diseases |
| 06/14/2006 | EP1272236B1 Methods and compositions for treating intervertebral disc degeneration |
| 06/14/2006 | EP1267851B1 Compositions comprising carotenoids and use thereof for preventing hormone induced adverse effects |
| 06/14/2006 | EP1261361B1 Oral, nasal and pulmonary dosage formulations of copolymer 1 (glatiramer acetate) |
| 06/14/2006 | EP1214324B1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
| 06/14/2006 | EP1165085B1 Phthalazine derivatives for treating inflammatory diseases |
| 06/14/2006 | EP1071439B1 Rose-hip formulations as anti-inflammatory natural medicine for alleviating/reducing symptoms associated with inflammation and arthritis |
| 06/14/2006 | CN1788007A Crystal of benzimidazole derivative and process for producing the same |
| 06/14/2006 | CN1787832A Method of treating inflammtory disease associated with bone destruction |
| 06/14/2006 | CN1787825A External patch containing estrogen and/or progestogen |
| 06/14/2006 | CN1787807A Method of preparing a formulation containing a microdosed active component |
| 06/14/2006 | CN1786017A Renaturation of reconstituted human bone protein-1 and making method of its preparation |
| 06/14/2006 | CN1785424A Bone growth penta peptide medicinal composition ant its preparation method |
| 06/14/2006 | CN1785378A Medicine for treating cervical vertebra disease |
| 06/14/2006 | CN1785364A Bone joining medicine |
| 06/14/2006 | CN1785349A Medicinal wine for treating knocks and falls |
| 06/14/2006 | CN1785331A Chinese herbal medicine composition for treating bone fracture and osteomiosis |
| 06/14/2006 | CN1785321A Chinese medicinal composition for quicheking bone fracture agglutination |
| 06/14/2006 | CN1785304A Guxian medicinal preparation for treating osteoproliferation and its preparation method |
| 06/14/2006 | CN1785276A Medicine for treating atrophic arthritis |
| 06/14/2006 | CN1785268A Quality control method of sinew soothing and pain relieving preparation |
| 06/14/2006 | CN1785238A Application of pulvis pro clavus extractive total flavone in preparing anti-inflammatory agent |
| 06/14/2006 | CN1785237A Duyiwei dripping pill prepn. and its preparing method |
| 06/14/2006 | CN1785222A Injection liquid contg. Kudiezi, and its powder injection |
| 06/14/2006 | CN1785214A Extractives of pearl nacre mother protein and its application |
| 06/14/2006 | CN1785211A Method for treating and eliminating hyperosteogeny |
| 06/14/2006 | CN1785182A Glassiness sosoloid contg. 2-(3-cyano-4-isobutoxyphenyl)-4-methyl-5-thiazol formic-acid and polyvinyl pyrrolidone and its prepn. method |
| 06/14/2006 | CN1785159A Method for preparing bathing mud made of flowers |
| 06/14/2006 | CN1785018A Method for preparing milk contg. micron ginseng, tortoise, pearl and pollen for tonifying-Yin, dispelling-fatigue and enriching-calcium |
| 06/14/2006 | CN1785015A Method for preparing soymilk tablets contg. micron ginseng, tortoise, pearl and pollen for tonifying-Yin, dispelling-fatigue and enriching-calcium |
| 06/14/2006 | CN1785014A Method for preparing milk powder contg. micron ginseng, tortoise, pearl and pollen for tonifying-Yin, dispelling-fatigue and enriching-calcium |
| 06/14/2006 | CN1785013A Method for preparing soymilk powder contg. micron ginseng, tortoise, pearl, pollen for tonifying-Yin, dispelling-fatigue and enriching calcium |
| 06/14/2006 | CN1785012A Method for preparing milk contg. micron ginseng, antler, pearl and pollen pini for tonifying-Yang, dispelling-fatigue and enriching-calcium |
| 06/14/2006 | CN1785011A Method for preparing soymilk contg. micron ginseng, antler. pearl and pollen pini for tonifying-Yang, dispelling-fatigue and enriching-calcium |
| 06/14/2006 | CN1785010A Method for preparing milk tablets contg. micron ginseng, antler, pearl, and pollen pini for tonifying-Yang, dispelling-fatigue and enriching-calcium |
| 06/14/2006 | CN1785008A Method for preparing milk powder contg. micron ginseng, antler, pearl and pollen pini for tonifying-Yang, dispelling-fatigue and enriching-calcium |
| 06/14/2006 | CN1785007A Method for preparing soymilk powder contg. micron ginseng, antler, pearl and pollen pini for tonifying-Yang, dispelling-fatigue and enriching-calcium |
| 06/14/2006 | CN1784995A Method for preparing sour soymilk contg. micron ginseng, tortoise, pollen and pearl for tonifying-Yin, dispelling-fatigue and enriching-calcium |
| 06/14/2006 | CN1784994A Method for preparing sour milk contg. micron ginseng, antler, pearl, and pollen pini for tonifying-Yang, dispelling-fatigue and enriching-calcium |
| 06/14/2006 | CN1784993A Method for preparing sour soymilk contg. micron ginseng, antler pearl and pollen pini for tonifying-Yang, dispelling-fatigue and enriching-calcium |
| 06/14/2006 | CN1259337C Synthesis, expression, preparation and application for human parathyroid hormone gene mutant |
| 06/14/2006 | CN1259325C Diphosphate, preparation and uses of its pharmaceutical preparations |
| 06/14/2006 | CN1259307C Acylated indanyl amines and their use as pharmaceuticals |
| 06/14/2006 | CN1259097C Chinese medicinal preparation for treating osteoproliferation and various rheumatalgia |
| 06/14/2006 | CN1259096C A process of preparing medicinal liquor for treating rheumatism and rheumatoid disease |
| 06/14/2006 | CN1259083C Hyperostereogeny treating medicine |
| 06/14/2006 | CN1259079C Osteopathy treating ointment |
| 06/14/2006 | CN1259072C Medicine for treating rheumatic or rheumatoid arthritis and its preparation method |
| 06/14/2006 | CN1259065C Chinese medicinal preparation for quick bone fracture setting |
| 06/14/2006 | CN1259044C Bone metabolism improving agents |
| 06/13/2006 | US7060836 Lactams as tachykinin antagonists |
| 06/13/2006 | US7060821 Osteoclast differentiation inhibitors |
| 06/13/2006 | US7060802 Monoclonal antibody hybridomas ; detecting cancer |
| 06/13/2006 | US7060716 Compound containing two triple bonds |
| 06/13/2006 | US7060707 Isoquinoline derivatives |
| 06/13/2006 | US7060701 piperidines or piperazines 1-linked to a 1-(1-carbonylpiperidin-4-yl)piperidinyl- group through an optionally substituted methyl group; treating Human Immuno-deficiency Virus, solid organ transplant rejection, arthritis, rheumatoid arthritis, and multiple sclerosis |
| 06/13/2006 | US7060700 Amide derivatives useful as inhibitors of the production of cytokines |
| 06/13/2006 | US7060685 Benzylaminosulfonic Acid or portion or analogue linked to a carbohydrate or glycomimetic for modulating processes mediated by selectin binding such as autoimmune and inflammatory diseases, shock and reperfusion injuries |
| 06/13/2006 | US7060683 for treatment of neurodegeneration, stroke, Alzheimer's, amyotrophy, motor neuron damage, acute central nervous system injury, muscular dystrophy, bone resorption, platelet aggregation, cataracts and inflammation |
| 06/13/2006 | US7060681 Compositions and methods for use of bioactive agents derived from sulfated and sulfonated amino acids |
| 06/13/2006 | US7060472 Preparing calcium phosphate nanoclusters for use in treatment of bone disorders; obtain nanocluster solution, adjust hydrogen ion concentration, recover calcium phosphate nanocluster |
| 06/08/2006 | WO2006060810A1 Sulfonamide compounds as cysteine protease inhibitors |
| 06/08/2006 | WO2006060698A1 Nanoparticulate benzothiophene formulations |
| 06/08/2006 | WO2006060632A1 Systems for providing a reference plane for mounting an acetabular cup |
| 06/08/2006 | WO2006060494A1 Haloalkyl containing compounds as cysteine protease inhibitors |
| 06/08/2006 | WO2006059945A1 Novel compounds |
| 06/08/2006 | WO2006059778A1 Substituted pyridone derivative |
| 06/08/2006 | WO2006059714A1 Composition for prevention and/or treatment of bone diseases, physiologically functional or health foods containing the composition, and medicinal preparations containing the composition as the active ingredient |
| 06/08/2006 | WO2006059329A1 Platelet-derived microparticles for therapy |
| 06/08/2006 | WO2006010503A3 Rxr antagonists in the treatment of inflammatory diseases |
| 06/08/2006 | US20060122392 Tri-heterocyclic compounds and a pharmaceutical comprising them as an active ingredient |
| 06/08/2006 | US20060122390 Boronic ester and acid compounds, synthesis and uses |
| 06/08/2006 | US20060122374 Albumin-fused anti-angiogenesis peptides |
| 06/08/2006 | US20060122370 Specific binding agents of human angiopoietin-2 |
| 06/08/2006 | US20060122274 Such as strontium glutamate, strontium malonate, and strontium alpha-ketoglutarate; osteoporosis, osteopenia |
| 06/08/2006 | US20060122268 Such as N1-(1-cyanocyclopropyl)-4-fluoro-N2-((1S)-2,2,2-trifluoro-1-(4' -(methylsulfonyl)-1,1'-biphenyl-4-yl) ethyl)-L-leucinamide; for treating osteoporosis and other bone loss disorders |
| 06/08/2006 | US20060122249 Condensed heterocyclic pyrazole derivatives as kinase inhibitors |
| 06/08/2006 | US20060122234 Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors |
| 06/08/2006 | US20060122221 N-[4-methyl-3-(3-piperidin-4-yl-1,2-benzisoxazol-6-yl)phenyl]-2-pyrrolidin-1-ylisonicotinamide; rheumatoid arthritis |
| 06/08/2006 | US20060122215 Preparation and use of 1,5,6,7-tetrahydropyrrolo[3,2-C]pyridine derivatives for the treatment of obesity |
| 06/08/2006 | US20060122212 Bicyclic heteroaromatic compounds as kinase inhibitors |
| 06/08/2006 | US20060122176 such as 5-(1,3-benzodioxol-5-ylmethylene)-1,3-thiazolidine-2,4-dione, used for the treatment and/or prophylaxis of autoimmune, cardiovascular or neurodegenerative disorders, inflammatory or kidney diseases, bacterial or viral infections, platelet aggregation, cancer, transplant rejection or lung injuries |
| 06/08/2006 | US20060122173 Il-8 receptor antagonists |
| 06/08/2006 | US20060122147 Combination preparation of hyaluronic acid and at least oe local anesthetic and the use thereof |
| 06/08/2006 | US20060121514 Prostacyclin-stimulating Factor-2 |
| 06/08/2006 | US20060121180 Using electrochemical solution containing metal compound and bioactive materials; contacting substrate |
| 06/08/2006 | US20060121132 TNF-alpha production inhibitor comprising kavalactone as an active ingredient |
| 06/08/2006 | US20060121079 Delivering a dose of gold, silver or an alloy of particles having a cross-sectional diameter of >20 mu m and the same weight but a greater surface area than that of solid spheres; direct contact with tissue to release ions for uptake by macrophages without phagocytosis of particles; immunocompetence |
| 06/08/2006 | US20060121033 Using antibodies which bind specifically to DC-SIGN; Agents that bind to ICAM-3 are used to block inhibition of activation of macrophages by DC-SIGN-ICAM-3 interaction and cause inhibition of rheumatoid arthritis symptoms |
| 06/08/2006 | US20060121015 Probiotic bifidobacterium strains |
| 06/08/2006 | CA2589824A1 Nanoparticulate benzothiophene formulations |
| 06/08/2006 | CA2588867A1 Substituted pyridone derivative |
| 06/08/2006 | CA2588739A1 Systems for providing a reference plane for mounting an acetabular cup |
| 06/07/2006 | EP1666883A1 Diagnostic and monitoring methods for bone loss |
| 06/07/2006 | EP1666594A2 Polypeptide, nucleic acid encoding it, and their use for the diagnosis of cancer |
| 06/07/2006 | EP1666497A2 Polypeptide, nucleic acid encoding it, and their use for the diagnosis of cancer |
| 06/07/2006 | EP1666493A1 Secreted and transmembrane polypeptides and nucleic acids ancoding the same |
| 06/07/2006 | EP1666492A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |